Podcasts about safer so why are we driving people

In this episode, The Disagreement asks a wide range of important questions about marijuana legalization.Is marijuana harmful? And if so, what is the nature of the harm?Has the increasing regulation of marijuana over the past few years been positive or negative for public health, criminal justice, and the US economy?What are the most compelling arguments for and against regulation? GuestsPaul Armentano is the Political Director for the National Organization for the Reform of Marijuana Laws (NORML) and a leading national advocate for legalizing marijuana. He has written many books and policy papers, including: Marijuana is Safer: So Why Are We Driving People to Drink? and Emerging Clinical Applications for Cannabis and Cannabinoids.Dr. Stuart Gitlow is a psychiatrist and internationally recognized addiction expert. He previously served as President of the American Society of Addiction Medicine. In 2016, he testified before the Senate Judiciary Committee opposing the legalization of marijuana. He is the author of Substance Use Disorders: A Practical Guide. Show NotesComparison with seatbelt laws [05:12]Effects on criminal justice [07:15]Economic impacts [11:29]Impact on productivity [12:52]Public health implications [14:36]Comparison with alcohol [17:27]Substance dependence [19:39]Basis of addictive disease [23:03]Profit motive [26:50]Issue of psychosis [31:46]Impact of THC on psychosis [34:14]Steelmanning [37:26] ResourcesLink to the Lancet study referenced in the podcast on cannabis use and psychosisLink to a Journal of the American Medical Association study that shows the disproportionate impact of anti-marijuana laws on African-Americans

Marijuana and marijuana policy with Paul Armentano. Paul is the deputy director of the National Organization for the Reform of Marijuana Laws (NORML) and the NORML Foundation in Washington, D.C. Armentano has written on the subject of marijuana and marijuana policy. His work has appeared in over 200 publications, including more than a dozen textbooks and anthologies, and he is a frequent contributor to AlterNet, High Times, The Huffington Post, and the Washington, D.C. newspaper The Hill. Armentano is a 2008 recipient of the 'Project Censored Real News Award for Outstanding Investigative Journalism' and was selected as one of America's 'Top 20 Young Visionaries' by Who Cares Magazine, a national quarterly journal devoted to community service and social activism. He has co-written a book about cannabis and social policies, Marijuana is Safer: So Why Are We Driving People to Drink?, which was published in 2009 through Chelsea Green Publishing.

Will marijuana legalization happen in the south next? Deputy Director of NORML (National Organization for the Reform of Marijuana Laws) Paul Armentano comes to Coastal Noise to talk southern state reform, what legal states are showing us now, shifting public opinion, and what actions southern states can take to end prohibition. Subscribe to Coastal Noise on iTunes, Youtube, Google Play or listen with the included link.   About Paul Armentano: Paul Armentano is the Deputy Director of NORML and faculty member at Oaksterdam Unviversty. His writing and research has appeared in over 750 publications, scholarly and/or peer reviewed journals, as well as more than a dozen textbooks and anthologies. He is a regular contributor to TheHill.com, AlterNet.org, and Freedom Leaf. Mr. Armentano is the co-auothr of "Marijuana is Safer: So Why Are We Driving People to Drink?" which has been licensed and translated internationally. His latest book is called "The Citizen's Guide to State-By-State Marijuana Laws". He is the 2013 Freedom Law School  Health Freedom Champion of the Year and the 2013 Alfred R. Lindesmith award recipient in the achievement in the field of scholarship.             Mr. Armentano was the principal investigator for defense counsel in US vs Schweder, the first federal evidentiary since 1973 hearing to challenge the constitutionality of cannabis as a schedule one controlled substance. He was also an expert in a successful Canadian constitutional challenge (Crown versus Allard) preserving qualified patients' rights to grow cannabis at home. Mr. armentano previously provided online content to the TheAnswerPage.com, an online medical educational resource that provides daily education to healthcare professionals in 120 countries, as well as Continuing Medical Education credit. A version of this curriculum is now required in New York state for any physician who wishes to participate in the state's medical cannabis program.   About NORML: The National Organization for the Reform of Marijuana Laws. Since its founding in 1970, NORML has provided a voice in the public policy debate for those Americans who oppose marijuana prohibition and favor an end to the practice of arresting marijuana smokers. A nonprofit public-interest advocacy group, NORML represents the interests of the tens of millions of Americans who smoke marijuana responsibly. NORML's mission is to move public opinion sufficiently to legalize the responsible use of marijuana by adults, and to serve as an advocate for consumers to assure they have access to high quality marijuana that is safe, convenient and affordable. (Fyi : NORML has a great newsletter that I have been subscribed to for almost ten years. Check it out.)   Show Notes:   -Marijuana in the main stream (over half of the US polling YES for legalization)   -What we're learning from legal states - - - "We have not seen [in the 30 states] that have enacted marijuana laws, starting with California in 1996...not a single one of those states has ever gone back and recriminalized marijuana."   -Lack of uptick in use with young teens or access in jurisdictions where marijuana is regulated.   -Paul Armentano Video Lecture : "Facts vs. Fears : Countering Common Misconceptions about Medicinal Cannabis" - - - "The most frustrating aspect of marijuana policy in America [at the federal level] is we do not have an evidence based policy...[it is] 180 degrees removed from what relevant science is telling us."   -Using PubMed to research Marijuana - - - "Outside of tabbaco, marijuana is the most studied plant on Earth...[there is] nearly 26,000 individual, peer reviewed studies of marijuana...That is more than twice the volume of literature dedicated to Ibeprofin...It's more than 20 times the available literature to hydrocodone."   -"We have a long history of human use than we have conventional substances we consume everyday...The problem isn't we don't know enough about cannabis, [it's that] we have public policies that are divorced from what the available science tells us."   -The Ole Miss Federal Marijuana Farm and how it is used for clinical research across the country   -The Compassionate Investigational New Drug Program of 1978 and the patients who receive 300 rolled marijuana cigarettes a month from the US Government & what studies on these patients tell us.   -Why was marijuana originally made illegal?   -Creating change where prohibition still exists   Hosted by Stefan Lawson. 8/8/17   Please subscribe, share, leave reviews, or comments. We would love to hear your feedback.   Subscribe on iTunes here     Subscribe on Youtube here

As the High Holiday of the Cannabis Calendar (4/20!) is upon us, Dr. Kelly invites NORMLs Deputy Director Paul Armentano to share with us his thoughts on the current state of cannabis legalization, policy and scientific efficacy in the US in 2017! What does this year hold for legal cannabis in America? Remember that 4-19 is Take Action Day for cannabis reform day, and you can find out more here: norml.org/act While more Americans than ever before favor the legalization of both recreational and medical cannabis, and over 30 states currently have legal medical dispensary systems, cannabis remains firmly on the DEAs Federal Schedule 1, classified to have no accepted medical value. Adding to this confusion is our new President and Attorney General offering confusing messages about the plant, and about federal involvement in state sanctioned marijuana programs. Today, Mr. Armentano addresses what he describes as the ignorance and political apathy on the part of lawmakers, and political inertia that continues to maintain this flat earth policy regarding federal legalization and scheduling. But what does the science and research really show? Mr. Armentano shares with Dr. Kelly today some of the common misconceptions about cannabis, as well on going research on its public health benefits (including helping curb the opiate epidemic). We also discuss a recent literature review of over 10,000 studies on cannabis shows its efficacy in treating conditions like chronic pain, nausea, epilepsy, MS and more. In this interview, we address the political climate including: What does this new administration hold for cannabis legalization over the next year? What is the current federal legality of CBDs? Will the office of drug czar be abolished? Will state mandated cannabis programs be subject to federal law? Will cannabis ever be removed from Schedule 1, and what will it take for this to happen? How can people get involved at state and federal levels to let their voice be heard? Paul Armentano is the Deputy Director of NORML, the National Organization for the Reform of Marijuana Laws, and also serves as a faculty member at Oaksterdam University. His writing and research have appeared in over 750 publications, scholarly and/or peer-reviewed journals, as well as in more than a dozen textbooks and anthologies. He is a regulator contributor to TheHill.com as well as to numerous other print and online publications, including Freedom Leaf and Alternet.org. Mr. Armentano is the co-author of the book Marijuana is Safer: So Why Are We Driving People to Drink? which has been licensed and translated internationally. His most recent book, The Citizens Guide to State-By-State Marijuana Laws (2015), is available from Whitman Publishing.

In a recent decision, the Drug Enforcement Administration ruled that marijuana will remain a Schedule 1 substance under the Controlled Substances Act. Substances in Schedule 1 are determined by the Food and Drug Administration to be drugs with no currently accepted medical use and a high potential for abuse.   On Lawyer 2 Lawyer, host J. Craig Williams joins Paul Armentano, deputy director of NORML and Ben Cort, business development manager for the Center for Addiction Recovery and Rehabilitation (CeDAR), to discuss the recent decision by the DEA to keep marijuana on the Schedule 1 list. They will talk impact, the legalization of marijuana, manufacturing marijuana for scientific purposes, and what the future holds on this controversial topic. Paul Armentano is deputy director of NORML, and the National Organization for the Reform of Marijuana Laws, and a senior policy advisor at Freedom Leaf, Inc: The Marijuana Legalization Company. He is the co-author of the book “Marijuana is Safer: So Why Are We Driving People to Drink?” Paul was also the principal investigator for defense counsel in U.S. v Schweder, the first federal evidentiary since 1973 hearing to challenge the constitutionality of cannabis as a schedule I controlled substance. Ben Cort is business development manager for the Center for Addiction Recovery and Rehabilitation (CeDAR), part of the University of Colorado Health system. Ben’s passion for recovery, prevention and harm reduction comes from his own struggle with substance abuse. Sober since 1996, Cort is also a junior fellow at the University of Florida’s Drug Policy Institute and serves on the boards of Project SAM (Smart Approaches to Marijuana) and the Stout Street Foundation. Special thanks to our sponsor, Clio.

Paul Armentano is the Deputy Director of NORML and the NORML Foundation. Mr. Armentano is an expert in the field of marijuana policy, health, and pharmacology, and has served as a consultant for Health Canada and the Canadian Public Health Association. He has spoken at numerous national conferences and legal seminars, testified before state legislatures and federal agencies, and assisted dozens of criminal defense attorneys in cases pertaining to the use of medicinal cannabis, drug testing, and drugged driving. He is a frequent guest on radio, and has appeared frequently on the nationally syndicated Dr. Drew Pinsky show. Mr. Armentano is a prolific writer on the subject of marijuana and marijuana policy. His work has appeared in over 500 publications, including the New York Times, Washington Post, and The Christian Science Monitor. His writing has been featured in more than a dozen textbooks and anthologies, and he is a frequent contributor to AlterNet, High Times, The Huffington Post, and the Washington, D.C. newspaper The Hill. Mr. Armentano is a 2008 recipient of the 'Project Censored Real News Award for Outstanding Investigative Journalism,' and is the co-author of the book Marijuana is Safer: So Why Are We Driving People to Drink? (2009, Chelsea Green). He lives in northern California and is a frequent speaker at Oaksterdam University in Oakland.

Recently reports proliferated that in the House of Representatives, during the government shutdown, while meeting late into the night, the smell of booze was rampant.  Perhaps if they had been smoking pot, instead of drinking alcohol, the government would never have been shut down and there might be a whiff more bipartisanship.Sound ridiculous? Well if it had been the Colorado or Washington legislature, it might very well be the case.  In fact the legalization of marijuana seems to be an idea whose time has come. Recent votes in Colorado and Washington, coupled with the twenty states already allowing medical marijuana, and the decision by the Justice Department to rescind prosecutions, are all key sign posts along the way.A key player in this effort, who was also instrumental in Colorado's recent decision to legalize even recreational use, is Paul Armentano.  He's the co-author of Marijuana is Safer: So Why Are We Driving People to Drink? My conversation with Paul Armentano:

Our guest is Mason Tvert, co-author of Marijuana is Safer: So Why Are We Driving People to Drink? and executive director of saferchoice.org.